Skip to main navigation Skip to search Skip to main content

Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

  • G Le Teuff
  • , A Castaneda-Heredia
  • , C Dufour
  • , T Jaspan
  • , R Calmon
  • , A Devos
  • , K McHugh
  • , P Leblond
  • , D Frappaz
  • , I Aerts
  • , C.M. Zwaan
  • , S Ducassou
  • , P Chastagner
  • , A Verschuur
  • , N Corradini
  • , M Casanova
  • , H Rubie
  • , R Riccardi
  • , MC le Deley
  • , G Vassal
  • B Geoerger

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
Original languageUndefined/Unknown
Article numbere28032
JournalPediatric Blood and Cancer
Volume67
Issue number1
DOIs
Publication statusPublished - 2020

Research programs

  • EMC MM-02-54-03

Cite this